00000000cam 2200000zi 4500
0019.954694
003CaOODSP
00520260121084723
006m     o  d f      
007cr cn|||||||||
008250902t20252025onc     ob   f000 0 eng d
020 |a9780660787336
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH134-45/2025E-PDF
24500|aCompliance promotion : |bcomplaint investigations, adverse reaction reporting, and record keeping under the cannabis regulations.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c[2025]
264 4|c©2025
300 |a1 online resource (6 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCaption title.
500 |aIssued also in French under title: Promotion de la conformité : enquêtes sur les plaintes, déclaration des effets indésirables et tenue de dossiers conformément au règlement sur le cannabis.
504 |aIncludes bibliographical references (page 5).
520 |a"At Health Canada, we are committed to supporting cannabis licence holders (LHs) in achieving high standards of regulatory compliance. Following recent inspections of LHs, Health Canada would like to bring to your attention certain requirements under the Cannabis Regulations (CR) related to adverse reactions, particularly in the area of complaint investigations and adverse reaction reporting"--Page [1].
650 0|aMarijuana industry|xLicenses|zCanada.
650 0|aCannabis|xSafety regulations|zCanada.
650 0|aCannabis|xSide effects|xReporting|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tPromotion de la conformité : |w(CaOODSP)9.954693
85640|qPDF|s248 KB|uhttps://publications.gc.ca/collections/collection_2026/sc-hc/H134-45-2025-eng.pdf
986 |a250212